AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-106008606/idec-pharmaceuticals-seacoast-near.html" title="Facts and information about Idec Pharmaceuticals, Seacoast Near Highs.(B)(NASDAQ STOCKS IN THE NEWS)">Idec Pharmaceuticals, Seacoast Near Highs.(B)(NASDAQ STOCKS IN THE NEWS)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
Idec Pharmaceuticals, Seacoast Near Highs.(B)(NASDAQ STOCKS IN THE NEWS)
Byline: Christina Wise
Idec Pharmaceuticals has worked its way back to within 9% of the top of the base it began back in December 2000.
The San Diego-based drug maker's product line includes Rituxan, which is used to treat non-Hodgkin's lymphoma.
After hitting the triple digits in late 1999 and early 2000, Idec's earnings growth rate has slowed slightly in recent quarters.
Second-quarter profit rose 67% and third-quarter profit grew 60%. Analysts surveyed by First Call expect fourth-quarter profit to climb 33%. Overall, earnings are expected to swell 64% in 2001 and 54% in 2002.
...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- IDEC PHARMACEUTICALS REPORTS 1995 RESULTS
- Press release article from: PR Newswire February 15, 1996 700+ words
...Results In Fourth Quarter Profit SAN DIEGO, Feb...PRNewswire/ -- IDEC Pharmaceuticals Corporation...development work. IDEC Pharmaceuticals ended 1995 with...good year for IDEC Pharmaceuticals," noted William...
- Idec's quarterly earnings show solid growth: Genetronics raises $15.67 million...
- Magazine article from: San Diego Business Journal Webb, Marion July 28, 2003 700+ words
Idec Pharmaceuticals Corp., which recently signed an agreement to buy Biogen Inc...biotechnology, which sells two cancer drugs, said its second-quarter profit fell to $28.8 million, or 17 cents a share, which compares...
- IDEC PHARMACEUTICALS AND SMITHKLINE BEECHAM EXPAND 'PRIMATIZED' ANTIBODY...
- Press release article from: PR Newswire February 22, 1993 700+ words
...Feb. 22 /PRNewswire/ -- IDEC Pharmaceuticals Corporation (NASDAQ: IDPH) and...terms of the amended agreement, IDEC Pharmaceuticals will receive up to $20 million...therapeutic antibodies developed by IDEC Pharmaceuticals. Differing significantly from other...
- IDEC PHARMACEUTICALS REPORTS ACCELERATED INVESTMENT BY GENENTECH
- Press release article from: PR Newswire May 13, 1996 700+ words
...DIEGO, May 13 /PRNewswire/ -- IDEC Pharmaceuticals Corporation (Nasdaq: IDPH) today...of the original agreement between IDEC Pharmaceuticals and Genentech for IDEC-C2B8...weighted average trading price of IDEC Pharmaceuticals Common Stock following the earlier...
- IDEC PHARMACEUTICALS STARTING TO UNIFY FACILITIES AND STAFF IN SAN DIEGO
- Press release article from: PR Newswire February 22, 1993 700+ words
...Feb. 22 /PRNewswire/ -- IDEC Pharmaceuticals Corporation (NASDAQ: IDPH) today...June. As previously announced, IDEC Pharmaceuticals has leased a 70,000-square...accelerate the development process." IDEC Pharmaceuticals is focused on the development of...
- IDEC PHARMACEUTICALS REPORTS FIRST QUARTER 1995 RESULTS
- Press release article from: PR Newswire May 1, 1995 700+ words
...DIEGO, May 1 /PRNewswire/ -- IDEC Pharmaceuticals Corporation (Nasdaq: IDPH...for the first quarter of 1994. IDEC Pharmaceuticals ended the first quarter with $20...realized significant validation of both IDEC Pharmaceuticals' technology and business strategy...
- IDEC PHARMACEUTICALS LICENSES PATENT RIGHTS FROM THE WISTAR INSTITUTE
- Press release article from: PR Newswire December 11, 1991 700+ words
IDEC PHARMACEUTICALS LICENSES PATENT RIGHTS FROM...Dec. 11 /PRNewswire/ -- IDEC Pharmaceuticals Corp. (NASDAQ: IDPH) has...and chief executive officer of IDEC Pharmaceuticals. I-Mel-1 and I-Mel...
- IDEC PHARMACEUTICALS TAKES STEPS TO SPEED DEVELOPMENT OF PAN B ANTIBODIES FOR...
- Press release article from: PR Newswire December 5, 1991 700+ words
IDEC PHARMACEUTICALS TAKES STEPS TO SPEED DEVELOPMENT...Dec. 5 /PRNewswire/ -- IDEC Pharmaceuticals Corp. (NASDAQ: IDPH) announced...responsive to radiation therapy. IDEC Pharmaceuticals has been conducting human clinical...